Literature DB >> 35240079

Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67?

Gabriele Antonarelli1, Carmine Valenza1, Erica L Mayer2, Sibylle Loibl3, Giuseppe Curigliano4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35240079     DOI： 10.1016/S1470-2045(21)00756-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer.

Authors:  Mengdi Chen; Weilin Chen; Deyue Liu; Weiguo Chen; Kunwei Shen; Jiayi Wu; Li Zhu
Journal:  Breast Cancer       Date:  2022-06-21       Impact factor: 3.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.